Kirsten Angela Macfarlane's most recent trade in RenovoRx Inc was a trade of 25,099 Stock Options (right to buy) done . Disclosure was reported to the exchange on Oct. 1, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
RenovoRx Inc | Kirsten Angela Macfarlane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 25,099 | 25,099 | - | - | Stock Options (right to buy) | |
RenovoRx Inc | Macfarlane Angela Kirsten | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 40,983 | - | - | Warrant Shares | |
RenovoRx Inc | Kirsten Macfarlane Angela | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 40,983 | - | - | Common Stock | |
RenovoRx Inc | Kirsten Angela Macfarlane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 25,099 | 25,099 | - | - | Stock Option (right to buy) | |
RenovoRx Inc | Kirsten Angela Macfarlane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 4,582 | 4,582 | - | - | Stock option (right to buy) |